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ABSTrACT
Hemin may be of potential therapeutic value in wound healing management in diabetics. It is an inducer of 
heme oxygenase-1, an enzyme which degrades heme and participates in cellular protection against oxidative stress, 
inflammation and apoptosis. Thus, in the present study, hemin (0.5%) was applied topically over excision wounds, and 
its therapeutic effect in wound healing evaluated in diabetic rats. Topical hemin application significantly increased the 
percentage of wound contraction on day 2 in diabetic rats, however, povidone-iodine did the same on day 7 compared 
to the diabetic control. A significant increase in hydroxyproline and glucosamine content was found on day 14 in the 
hemin treated wounds of diabetic rats vs. the diabetic control. The histology of the hemin treated rats was in agreement 
with the cellular proliferation and collagen synthesis in granulation tissue. Hemin significantly increases cytokine 
IL-10 and decreases TNF-α in the granulation tissue of the healed wounds of diabetic rats. The finding showing the 
pro-healing effects of hemin was endorsed by inhibition of mRNA expression of pro-inflammatory cytokine TNF-α 
and adhesion molecule ICAM-1, and up-regulation of anti-inflammatory cytokine IL-10 mRNA. Hence, topical hemin 
application (i) helps in early and fast wound contraction (ii) enhances the hydroxyproline and glucosamine content of 
wounds and (iii) modulates pro-healing mRNA expression of cytokines. 
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are essential for efficient wound healing (DONALD 
and ZACHARY, 2004). Normal wound healing 
proceeds slowly, and delay in wound healing 
are associated with infection, diabetes mellitus, 
immunosuppression, obesity and malnutrition 
Introduction
Diabetes mellitus is a disease known for 
delaying normal healing processes (SINGH et al., 
2005). The sequential influx of inflammatory cells, 
proliferation of stromal elements, growth of blood 
vessels and production of an extra-cellular matrix 
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Materials and methods
Experimental animals. Healthy male adult Wistar 
rats (200-250g) were housed in polypropylene cages 
with free access to standard balanced feed and water, 
in divisional animal houses. The experimental 
protocols were approved by the Institutional Animal 
Ethics Committee, which follows the guidelines for 
Care and Use of Laboratory Animals published by 
the US National Institute of Health (NIH, 1996). 
Diabetes induction. Freshly prepared 
streptozotocin solution (Sigma Chemicals) in 
a citrate buffer of pH 7.4 was administered to 
the rats at a dosage of 40 mg/kg body weight 
intraperitoneally (i.p.) to induce diabetes. Blood 
glucose levels were measured 48 hours after 
streptozotocin administration. Rats with fasting 
blood glucose levels greater than 200 mg/dL were 
selected for the experiment. Diabetic rats were kept 
under observation for a period of 7 days before 
creation of wounds (AHMAD et al., 2014).
Excision wound creation. Fifteen diabetic rats 
were housed at a room temperature of 22 ± 2 °C. 
The rats were anaesthetized using an intraperitoneal 
injection of Pentobarbital sodium at a dosage of 50 
mg/kg body weight. An open excision wound with 
an area of 2 × 2 cm2 was created to the depth of 
the loose subcutaneous tissue (AHANGER et al., 
2010). After recovery from anesthesia, the rats 
were housed individually in disinfected cages 
and divided into three groups, namely: Group I 
(Diabetic Control), Group II (Povidone iodine 
treated) and Group III (Hemin treated). Fifteen 
diabetic rats were used in this study with five rats in 
each group. Each rat was kept individually in a cage 
43x27x15 cm in size. 100 gms of simple ointment 
was prepared by the fusion method, containing soft 
paraffin (85g), hard paraffin (10g) and wool fat 
(5g). In Group-I the simple ointment was applied 
topically over the wounds of the diabetic rats once 
daily for 13 days. Povidone-ointment was topically 
applied to the wounds of Group II diabetic rats once 
daily for 13 days. For Group-III, hemin ointment 
(0.5%, Sigma Chemicals) in a simple ointment 
base was topically applied over the wound of the 
diabetic rats once daily for 13 days.
(GUPTA et al., 1999). Delayed wound healing is 
a recognized problem in diabetes mellitus. Despite 
some recent advances in our understanding of 
the mechanisms, impaired wound healing in 
diabetics continues to cause significant mortality 
or physical disability (FINE and MUSTOE, 
2006). Abnormalities resulting in impaired 
wound healing in diabetes include compromised 
neovascularization, a decrease in collagen synthesis, 
altered macrophage functions, and an increase in 
proteinase activity (FAHEY et al., 1991; LOOTS, 
1998).
Several studies have been published on the 
stress proteins expressed in the body during stress, 
and one such protein is heme oxygenase-1 (HO-1). 
HO is a rate-limiting enzyme in the catabolism of 
heme that leads to the formation of bile pigment 
biliverdin, carbon monoxide (CO) and free iron-
Fe2+ (ABRAHAM and KAPPAS, 2008). HO-1 
gene expression can be induced by diverse stimuli, 
such as xenobiotics, endocrine factors, metals, 
heat-shock, cytokines, endotoxins and oxidative-
stress (IMMENSCHUH and RAMADORI, 2000; 
SHIBAHARA et al., 1987). It is well documented 
that HO-1 speeds up wound healing (GROCHOT-
PRZECZEK et al., 2009; HANSELMANN et al., 
2001; KAMPFER et al., 2001). Degradation of 
heme participates in cellular defense by removing 
pro-oxidant heme, and increasing bilirubin and 
carbon monoxide, which contribute in cutaneous 
wound healing (AHANGER et al., 2011). Similarly, 
the strong prohealing effect of bilirubin has been 
explored in open excision cutaneous wounds in rats 
(AHANGER et al., 2016). 
Hemin, a hemoglobin component and an 
inducer of HO-1, has been approved by the U.S. 
Food and Drug Administration for treatment of 
acute porphyria. Hemin induces HO-1 and thus, 
has a therapeutic value in conditions where higher 
levels of HO-1s are desired. Previous studies in 
our laboratory have demonstrated the strong pro-
healing effects of hemin onto excision wounds in 
normo-glycemic rats (AHANGER et al., 2010). 
In the present study we directly applied hemin 
ointment (0.5%) to excision wounds created in 
diabetic rats.
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Wound area measurement. The surface area of 
the wound outline was measured using transparent 
paper on days 0, 2, 4, 7, 10 and 14 after creation of 
the wound. The area (mm2) within the boundaries 
of each tracing was determined planimetrically 
(AHANGER et al., 2011). The percentage of wound 
contraction was calculated as follows:
% wound contraction = 
Zero day wound area 
- unhealed wound area ×100
Zero day wound area
Biochemical parameters of wound. On day 14 
after wound creation, granulation tissue from the 
healed wound was excised to analyze the levels 
of hydroxyproline (WOESSNER, 1961) and 
glucosamine (RONDLE and MORGAN, 1995).
ELISA assay for IL -10 and TNF-α cytokines. 
The granulation tissue having been stored at -80 °C 
was pulverized in ice-cold lysis buffer containing 
100 mM Tris-HCl, 0.05 mM EDTA. About 50 
mg of granulation tissue, in 500 µL of lysis buffer 
and a pinch of glass wool, was pulverized with 
the help of a chilled pestle and mortar. Pulverized 
tissues were converted to a homogenous mixture, 
transferred into 1.5 mL micro-centrifuge tubes, 
and centrifuged for about 10 min at 10000 rpm. 
From the centrifuged mixture, supernatant protein 
lysate was collected for the further protocols. 
The ELISA protocol was followed as per the 
instructions provided (eBioscience Inc. Catalogue 
Nos 88-7340-22-TNF-α and 88-7104-22-IL-10). 
The total protein of the lysate was also estimated 
to express the value of cytokine on a w/w basis 
(LOWRY et al., 1951).
Histological studies. Granulation tissue from 
the skin, kept for analysis in 10% formalin solution, 
was subjected to sectioning. The 6 µm thick sections 
were stained with hematoxylin and eosin to show 
histological changes under a light microscope 
(LUNA, 1968).
mRNA expression studies. Granulation tissue 
was excised from healed wound tissue on day 14 
after wound creation and used to study expression 
of mRNA, cytokines IL-10, TNF-α and adhesion 
molecule ICAM-1. Total RNA was extracted 
using the QIAGEN RNeasy Mini-extraction kit 
(QIAGEN Ltd., Valencia, USA). cDNA synthesis 
was carried out using MMLV reverse transcriptase. 
Gene expression was determined using a real-
time PCR technique. Published primer sequences 
specific for rat IL-10, TNF-α, Intracellular Cell 
Adhesion Molecule-1 (ICAM-1) and β-actin were 
applied (AHANGER et al., 2010; AHANGER et 
al., 2016). β-actin was used as the house-keeping 
gene for relative quantitation of other expressed 
mRNAs.
Real-time PCR reactions were conducted on a 
Stratagene Q-Cycler and analyzed using Mx3000P 
software, with SYBR Green as the reference dye. 
To ascertain the specificity of the amplified product, 
dissociation curves were generated at temperatures 
55 °C to 95 °C. Results were expressed in terms 
of threshold cycle values (CT). To track relative 
change in gene expression, the 2-∆∆CT method 
was used (LIVAK and SCHMITTEN, 2001). This 
method was used to calculate the fold change in gene 
expression as: ‘Fold change = 2-∆∆ CT where ∆∆ 
CT = (CT of target gene - CT of β-actin) treatment 
- (CT of target gene- CT of β-actin) control.
Statistical analysis. Values were expressed as 
Mean ± SEM., with n being equal to the number 
of replicates. The statistical significance between 
the experimental and control values was analyzed 
by analysis of variance, followed by Dunnet’s test, 
using Graphpad Prism v4.03 software programme 
(San Diego, California, USA), and the differences 
between experimental and control groups were 
considered statistically significant at P<0.05.
results
Effect of Hemin on wound contraction. The 
effect of hemin on wound contraction was studied 
in excision wounds in diabetic rats on days 0, 2, 
4, 7, 10 and 14 (Fig.1.A). The hemin-treated group 
showed a significant increase in wound contraction 
on day 2 post-treatment; however, an equally 
significant change was recorded in the povidone-
iodine treated diabetic rats on day 7 onwards, 
compared to the diabetic control. Interestingly, 
hemin treatment initiated an early significant 
change in wound contraction from day 2, compared 
to povidone treatment from day 7 in the diabetes 
rats. 
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Fig. 1. The effect of topical application of hemin (0.5%) on (A). % wound contraction in diabetic rats and (B). 
ICAM-1 mRNA expression in wound granulation tissue on day 14 in diabetic rats.
Fig. 2. The effect of topical application of hemin (0.5%) on (A). hydroxyproline content and (B). glucosamine 
content in the granulation tissue of excision wounds on day 14 in diabetic rats
Fig. 3. The effect of topical application of hemin (0.5%) on (A). IL-10 levels and (B). TNF-α levels in granulation 
tissue on day 14 in diabetic rats
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Fig. 4. The effect of topical application of hemin on (A). IL-10 mRNA expression and (B). TNF-α mRNA 
expression in wound granulation tissue on day 14 in diabetic rats.
Fig. 5. The effect of topical application of hemin on wound granulation tissue on day 14 in diabetic-control rats (A 
& B); povidone iodine-treated diabetic group (C & D) and hemin treated diabetic group (E & F) in H and E stained 
under 40× and 100× magnification, respectively
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Effect of Hemin on the pro-healing constituents 
of the wound matrix (Hydroxyproline and 
Glucosamine). Hemin treatment significantly 
increased hydroxyproline content (16.44 ± 0.93 
mg/g tissue) in the granulation tissue of healed skin 
as compared to the diabetic control (11.05 ± 0.74 
mg/g tissue; Fig. 2.A). Hemin treatment significantly 
increased the glucosamine content of healed skin 
(5.20 ± 0.50 mg/g tissue) on day 14 of hemin-
treatment, as compared to the diabetic-control (2.21 
± 0.17 mg/g tissue). Similarly, povidone-iodine 
treatment also significantly increased glucosamine 
content compared to the diabetic-control (Fig. 2.B).
Effects of hemin on pro-healing inflammatory/
anti-inflammatory cytokines. Cytokine levels of 
IL-10 and TNF-α were assayed in the granulation 
tissue of diabetic rats following topical application 
of hemin, using an ELISA kit (Fig. 3.A & B). A 
significant increase in IL-10 levels was found in 
the granulation tissue of the hemin-treated diabetic 
rats (1100.9 ± 69.97 pg/mg of protein) compared 
to the diabetic-control rats (743.06 ± 32.72 pg/ mg 
of protein). In contrast, a significant reduction in 
TNF-α levels was found in the granulation tissue 
of the hemin-treated (45.76 ± 3.03 pg/mg protein) 
diabetic-rats compared to the diabetic-control rats 
(147.54 ± 3.85 pg/mg of protein). 
Effects of hemin on adhesion molecule 
(ICAM-1) and cytokine (IL-10 & TNF-α) mRNA 
expression. The relative expression of ICAM-1 
mRNA in response to hemin application, compared 
to the diabetic-control group, is presented in Fig. 
1.B. Hemin treatment significantly decreased the 
relative expression of ICAM-1 mRNA (0.35 ± 0.12 
folds) compared to the diabetic-control group. 
The effect of topical application of hemin on 
the relative expression of IL-10 mRNA in the 
granulation tissue of the wounds in the different 
experimental groups is depicted in Fig. 4.A. Hemin 
treatment produced a significant increase in the 
relative expression of IL-10 mRNA (5.13 ± 1.39 
folds) compared to the diabetic-control group. In 
povidone-treated rats, the mRNAs of IL-10 and 
ICAM-1 did not show significant change compared 
to the diabetic control.
Topical application of povidone and hemin on 
the wounds of diabetic rats elicited a significant 
reduction in the relative expression of TNF-α 
mRNA in the granulation tissue of the wounds 
(0.27 ± 0.10 folds) compared to the diabetic-control 
(Fig. 4.B). 
Histological findings. Diabetic-control rats 
showed loose and vacuolated granulation tissue with 
massive inflammation and a few necrotic patches 
(Fig. 5.A & B). Povidone iodine-treated wounds 
(Fig. 5.C & D) showed relatively better granulation 
tissue, epithelialization and less inflammatory cell 
infiltration compared to the diabetic-control rats. 
The hemin-treated wounds of diabetic rats (Fig. 
5.E & F) revealed compact and mature granulation 
tissue with dense epithelial lining and numerous 
neovascularization foci.
Discussion
Impairment of wound healing in diabetic mice 
has been attributed to delays in the transformation 
of fibroblasts to myofibroblasts and granulation 
tissue formation (DIPIETRO and BURNS, 2003). 
Topical application of hemin (0.5%) onto the 
excision wounds of the diabetic rats recorded about 
80% contraction on day 14 compared to 55% in the 
diabetic-control group. Delayed wound healing in 
diabetes was partially reversed through HO-1 over-
expression, which led to increased vascularization 
of wounded tissue (GROCHOT-PRZECZEK et al., 
2009).
Chronic wounds seen in diabetic patients 
are caught in the inflammatory phase featuring 
continuous influx of neutrophils that release 
cytotoxic enzymes, free radicals and inflammatory 
mediators, which results in extensive collateral 
damage to the surrounding tissue. These destructive 
processes lead to imbalance in the healing process 
and delayed repair (FALANGA, 2000). The 
povidone-iodine group revealed a significant effect 
on wound contraction in diabetic wounds from day 
7 onwards. This late effect may be attributed to the 
ability of povidone-iodine to keep the infection of 
the wound under control. Comparison of povidone-
iodine to silver sulphadiazine in topical treatment 
of flame and fluid burn wounds in humans has 
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demonstrated a better healing response with 
povidone-iodine (DEKOCK et al., 1989).
Impairment in the normal process of wound 
healing is present in diabetic patients. Several factors 
have been suggested to impair healing, such as 
impairment in neovascularization, reduced collagen 
synthesis, increased activity of proteinases, and 
defective immunological functions (LOOTS, 1998). 
LOOTS (1998) reported reduced collagen synthesis 
and extracellular matrix in diabetes. In the present 
study, hydroxyproline and glucosamine content 
was significantly increased in the granulation tissue 
of hemin-treated rats compared to diabetic-control. 
It has been found that the healing process 
inhibits expression of the pro-inflammatory 
mediator cytokines ICAM-1 and TNF-α and in 
contrast stimulates the anti-inflammatory mediator 
cytokine IL-10 (ABRAHAM and KAPPAS, 
2008). The prolonged persistence of neutrophils 
and macrophages in the wounds of diabetic 
mice (db/db mice) leads to higher levels of pro-
inflammatory mediators, such as IL-1α, IL-1β, 
IL-6 and TNF-α cytokines, which delays wound 
healing (WETZLER et al., 2000). Up-regulation of 
HO-1 through gene transfer in hyperglycemic rats 
demonstrated the arrest of endothelial sloughing, 
attenuation of glucose-mediated oxidative stress, 
DNA damage, and a reduction in cell death 
(SACERDOTI et al., 2005). Topical application 
of hemin (0.5%) onto wounds in diabetic rats led 
to pro-healing modulation of mRNA expression 
of adhesion molecules ICAM-1 and TNF-α, IL-
10 cytokines, meaning that ICAM-1 and TNF-α 
mRNA expression significantly decreased and 
expression of IL-10 mRNA was significantly 
enhanced in the hemin-treated rats compared 
to the diabetic-control. The interaction between 
leukocytes and endothelial cells plays a major 
role in the pathogenesis of inflammation, tissue 
repair, or tissue damage (CIOFFI et al., 1992). 
Therefore, inhibition of leukocyte infiltration in 
tissue would be an important step in reducing 
tissue injury and improving immune function. The 
adhesion molecule ICAM-1 mediates leukocyte 
adhesion, and correlates with the infiltration of 
leukocytes into inflammatory lesions (DEFAZIO 
et al., 2000; RAHMAN et al., 2002). ICAM-1 and 
other adhesion molecule expression is the initial 
marker of the inflammatory reactions involved 
in acute inflammatory reaction following injury 
(CUSCHIERI et al., 2003; DEVECI et al., 2000; 
MILESKI et al., 2003). Expression of TNF-α and 
IL-10 cytokines was modulated by hemin to favour 
prompt healing. Induction of HO-1 expression in 
obese diabetic mice demonstrated a reduction in 
plasma TNF-α, IL-6 and IL-1β levels (LI et al., 
2008). Bilirubin was found to reduce oxidative 
stress in experimental diabetes by inhibiting PKC 
and NADPH oxidase. This may be one mechanism 
by which HO-1 attenuates the diabetes-mediated 
generation of oxidant radicals (ABRAHAM and 
KAPPAS, 2008). We have also demonstrated the 
strong pro-healing effect of bilirubin in non-diabetic 
rats (AHANGER et al., 2016). Furthermore, 
induction of HO-1 expression in diabetic obese 
mice demonstrated a reduction in plasma TNF-α, 
IL-6 and IL-1β levels (LI et al., 2008). 
Histological evaluation involved morphometric 
evaluation of re-epithelialization, wound 
contraction, the maturity of granulation tissue, 
angiogenesis and inflammation. It is well known that 
modulation of fibroblasts toward a myofibroblast 
phenotype is essential for tissue remodeling during 
normal and pathological wound healing (CONRAD 
et al., 1993; TOMASEK et al., 2002). Weak and 
slow wound contraction in db/db mice has been 
attributed to delayed myosin appearance due to 
the altered conditions in the wound milieu. The 
diabetic control rats showed loose and vacuolated 
granulation tissue with massive inflammation and 
a few necrotic patches. Povidone iodine-treated 
wounds showed relatively better granulation tissue, 
but there was mild inflammatory cell infiltration. 
Epithelialization was also better than in the 
diabetic-control group. The hemin-treated group 
revealed relatively loose granulation tissue, but the 
epithelial lining was dense and there were numerous 
neovascularization foci. Re-epithelialization was 
seen to play a major role in wound healing in db/db 
mice, and impaired contraction was the main reason 
for delayed wound closure (IVETIC et al., 2009).
In conclusion, the present study showed that 
topical application of hemin onto the wounds of 
diabetic rats significantly improved the process of 
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wound healing. Thus, hemin topical application led 
to: i) early and fast wound contraction in diabetic 
rats, ii) significant enhancement in the constituents 
of the extracellular matrix of the granulation tissue 
of the wound and iii) pro-healing modulation 
of cytokines/adhesion molecules to regulate the 
inflammatory process that favors healing.
references
ABRAHAM, N. G., A. KAPPAS (2008): Pharmacological and 
clinical aspects of hemeoxygenase. Pharmacol. Rev. 60, 
79-127.
AHANGER, A. A., S. PRAWEZ, M. D. M. LEO, K. 
KATHIRVEL, D. KUMAR, S. K. TANDAN, J. K. MALIK 
(2010): Pro-healing potential of hemin: An inducer of heme 
oxygenase-1. Eur. J. Pharmacol. 645, 165-170.
 DOI: 10.1016/j.ejphar.2010.06.048
AHANGER, A. A., S. PRAWEZ, D. KUMAR, R. PRASAD, 
AMARPAL, S. K. TANDAN, D. KUMAR (2011): Wound 
healing activity of carbon monoxide liberated from CO- 
releasing molecule (CO-RM). N-S Arch. Pharmacol. 384, 
93-102.
 DOI: 10.1007/s00210-011-0653-7
AHANGER, A. A., M. D. M. LEO, A. GOPAL, V. KANT, S. 
K. TANDAN, D. KUMAR (2016): Pro-healing effects of 
bilirubin in open excision wound model in rats. Int. Wound 
J. 13, 398-402.
 DOI: 10.1111/iwj.12319
AHMAD, M., S. PRAWEZ, M. SULTANA, R. RAINA, N. 
K. PANKAJ, P. K. VERMA, S. RAHMAN (2014): Anti-
hyperglycemic, Anti-hyperlipidemic and Antioxidant 
potential of Alcoholic-extract of Sida cordifolia (Areal 
part) in Streptozotocin-induced-diabetes in wistar-rats. 
Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 84, 397-405.
 DOI: 10.1007/s40011-013-0218-2
CIOFFI, W. C., D. G. BURLESON, B. A. PRUITT (1992): 
Leukocyte responses to injury. Arch. Surg. 112, 860-865.
CONRAD, P. A., K. A. GIULIANO, G. FISHER, K. COLLINS, 
P. T. MATSUDARIA, D. L. TAYLOR (1993): Relative 
distribution of actin, myosin I, and myosin II during the 
wound healing response of fibroblasts. J. Cell Biol. 120, 
1381-1391.
 DOI: 10.1083/jcb.120.6.1381
CUSCHIERI, J., D. GOURLAY, I. GARCIA, S. JELACIC, 
R. V. MAIER (2003): Modulation of endotoxin-induced 
endothelial activity by microtubule depolymerization. J. 
Trauma. 54, 104-112.
 DOI: 10.1097/00005373-200301000-00013
DEFAZIO, G., B. NICO, M. TROJANO, D. RIBATTI, M. 
GIORELLI, F. RICCHIUTI, D. MARTINO, L. RONCALI, 
P. LIVREA (2000): Inhibition of protein kinase C 
counteracts TNF-α-induced ICAM-1expression and fluid 
phase endocytosis on brain microvascular endothelial cells. 
Brain Res. 863, 245-248.
 DOI: 10.1016/s0006-8993(00)02127-2
DEKOCK, M., A. E. VAN DER MERWE, C. A. STEWARTS 
(1989): A comparative study of povidone-iodine cream 
and silver sulphadiazine in the topical treatment of burns. 
Wounds. 1, 65-71.
DEVECI, M., M. ESKI, M. SENGEZER, U. KISA (2000): 
Effects of cerium nitrate bathing and prompt burn wound 
excision on IL-6 and TNF-α levels in burned rats. Burns. 
26, 41-45.
 DOI: 10.1016/s0305-4179(99)00107-2
DIPIETRO, L. A., A. L. BURNS (2003): Wound healing. 
Methods and protocols. Humana Press: Totowa, New 
Jersey.
DONALD, M., J. F. ZACHARY (2004): Pathological Basis of 
Veterinary Diseases, 4th ed., Elsevier Publication.
FAHEY, T. J., A. SADATY, W. G. JONES, A. BARBER, B. 
SMOLLER, G. T. SHIRSE (1991): Diabetes impairs the 
late inflammatory response to wound healing. J. Surg. Res. 
50, 308-318.
 DOI: 10.1016/0022-4804(91)90196-s
FALANGA, V. (2000): Classifications for wound bed 
preparation and stimulation of chronic wounds. Wound 
Repair Reg. 8, 347-352.
 DOI: 10.1111/j.1524-475x.2000.00347.x
FINE, N., T. MUSTOE (2006): Wound Healing. Philadelphia: 
Lippincott Williams & Wilkins.
GROCHOT-PRZECZEK, A., R. LACH, J. MIS, K. 
SKRZYPEK, M. GOZDECKA, P. SROCZYNSKA, 
M. DUBIEL, A. RUTKOWSKI, M. KOZAKOWSKA, 
A. ZAGORSKA, J. WALCZYNSKI, H. WAS, J. 
KOTLINOWSKI, J. DRUKALA, K. KUROWSKI, C. 
KIEDA, Y. HERAULT, J. DULAK, A. JOZKOWICZ 
(2009): Heme oxygenase-1 accelerates cutaneous wound 
healing in mice. PLoS ONE. 4, e5803.
 DOI: 10.1371/journal.pone.0005803
GUIDE FOR THE CARE AND USE OF LABORATORY 
ANIMALS, (1996): NIH Publication No. 85-23, revised.
GUPTA, A., G. K. JAIN, R. RAGHUBIR (1999): A time course 
study for the development of an immunocompromised 
wound model using hydrocortisone. J. Pharmacol. Toxicol. 
41, 183-187.
 DOI: 10.1016/s1056-8719(99)00041-6
HANSELMANN, C., C. MAUCH, S. WERNER (2001): Heme 
oxygenase-1: a novel player in cutaneous wound repair and 
psoriasis? Biochem. J. 353, 459-466.
 DOI: 10.1042/bj3530459
IMMENSCHUH, S., G. RAMADORI (2000): Gene regulation 
of heme oxygenase-1 as a therapeutic target. Biochem. 
Pharmacol. 60, 1121-1128.
 DOI: 10.1016/s0006-2952(00)00443-3
A. A. Ahanger et al.: Topical application of ‘Hemin’ promotes wound healing in Streptozotocin-induced diabetic rats
Vet. arhiv 91 (3), 287-296, 2021 295
IVETIC, V., T. EVIC, S. CUZIC, J.M. PARNHAM, I. 
PASALIC, K. BRAJSA (2009): Differential Evaluation of 
Excisional Non-occluded Wound Healing in db/db Mice. 
Toxicol. Pathol. 37, 183-192.
 DOI: 10.1177/0192623308329280
KAMPFER, H., N. KOLB, M. MANDERSCHEID, C. 
WETZLER, J. PFEILSCHIFTER (2001): Macrophage-
derived heme oxygenase-1: expression, regulation and 
possible functions in skin repair. Mol. Med. 7, 488-498.
 DOI: 10.1007/bf03401854
LI, M., D. H. KIM, P. TSENOVOY, S. J. PETERSON, 
R. REZZANI, L. F. RODELLA, W. S. ARONOW, S. 
IKEHARA, N. G. ABRAHAM (2008): Treatment of obese 
diabetic mice with a hemeoxygenase inducer reduces 
visceral and abdominal adiposity increases adiponectin 
levels and improves insulin sensitivity and glucose 
tolerance. Diabetes 57, 1526-1535.
 DOI: 10.2337/db07-1764
LIVAK, K. J., T. D. SCHMITTEN (2001): Analysis of relative 
gene expression data using real-time quantitative PCR and 
the 2(-DeltaDelta(CT). Methods 25, 402-408.
 DOI: 10.1006/meth.2001.1262
LOOTS, M. A. (1998): Difference in cellular infiltrate and 
extracellular matrix of chronic diabetic and venous ulcers 
versus acute wounds. J. Invest. Dematol. 11, 850- 857.
 DOI: 10.1046/j.1523-1747.1998.00381.x
LOWRY, O. H., N. J. ROSEBROUGH, A. L. FARR, R. J. 
RANDALL (1951): Protein measurement with the folin 
phenol reagent. J. Biol. Chem. 193, 265-275.
 DOI: 10.1016/s0021-9258(19)52451-6
LUNA, L. G. (1968): Manual of Histologic Staining Methods 
of the Armed Forces Institute of Pathology, 3rd ed., 
Mc.Graw Hill.
MILESKI, W. J., D. BURKHART, J. L. HUNT, R. J. KAGAN, 
J. R. SAFFLE, D. N. HERNDON, D. M. HEIMBACH, 
A. LUTERMAN, R. W. YURT, C. W. GOODWIN, J. 
HANSBOROUGH (2003): Clinical effects of inhibiting 
leukocyte adhesion with monoclonal antibody to 
intercellular adhesion molecule-1 (enlimomab) in the 
treatment of partial-thickness burn injury. J. Trauma. 54, 
950-958.
 DOI: 10.1097/01.ta.0000030626.84680.11
RAHMAN, A., A. L. TRUE, K. N. ANWAR, R. D. YE, T. 
A. VOYNO-YASENETSKAYA, A. B. MALIK (2002): 
Galpha(q) and Gbetagamma regulate PAR-1 signaling of 
thrombin- induced NF-kappa-B activation and ICAM-1 
transcription in endothelial cells. Cir. Res. 91, 398-405.
 DOI: 10.1161/01.res.0000033520.95242.a2
RONDLE, C. J. M., W. I. J. MORGAN (1955): The 
determination of glucosamine and galactosamine. 
Biochem. J. 61, 586-589.
SACERDOTI, D., R. OLSZANECKI, V. G. LI, C. 
COLOMBRITA, G. SCAPAGNINI, N. G. ABRAHAM 
(2005): Hemeoxygenase overexpression attenuates 
glucose-mediated oxidative stress in quiescent cell phase: 
linking heme to hyperglycemia complications. Curr. 
Neurovas. Res. 2, 103-111.
 DOI: 10.2174/1567202053586802
SHIBAHARA, S., M. MULLER, H. TAGUCHI (1987): 
Transcriptional control of rat hemeoxygenaseby heat 
shock. J. Biol. Chem. 262, 12889-12892.
 DOI: 10.1016/s0021-9258(18)45138-1
SINGH, N., D. G. ARMSTRONG, B. A. LIPSKY (2005): 
Preventing foot ulcers in patients with diabetes. JAMA. 
293, 217-228.
 DOI: 10.1001/jama.293.2.217
TOMASEK, J. J., G. GABBIANI, B. HINZ, C. CHAPONNIER, 
R. A. BROWN (2002): Myofibroblasts and mechano-
regulation of connective tissue remodeling. Nat. Rev. Mol. 
Cell. Biol. 3, 349-363.
 DOI: 10.1038/nrm809
WETZLER, C., H. KAMPFER, B. STALLMEYER, J. 
PFEILSCHIFTER, S. FRANK (2000): Large and sustained 
induction of chemokines during impaired wound healing 
in the genetically diabetic mouse: prolonged persistence 
of neutrophils and macrophages during the late phase of 
repair. J. Invest. Dermatol. 115, 245-253.
 DOI: 10.1046/j.1523-1747.2000.00029.x
WOESSNER, J. F. Jr. (1961): The determination of 
hydroxyproline in tissue and protein sample containing 
small proportions of this imino acid. Arch. Biochem. 
Biophys. 93, 440-447.
 DOI: 10.1016/0003-9861(61)90291-0 
Received: 20 May 2020
Accepted: 13 October 2020
_____________________________________________________________________________
AHAnger, A. A., S. PrAWez, A. SHAKoor, W. AHMAD, A. M. KHAn, D. KuMAr: Lokalna primjena 
hemina unapređuje liječenje rana u štakora s dijabetesom izazvanim streptozotocinom. Vet. arhiv 91, 287-296, 
2021.
Sažetak
Hemin ima potencijalnu terapijsku vrijednost u liječenju rana u dijabetičara. On potiče hem-oksigenazu-1, enzim 
koji razgrađuje hem i sudjeluje u staničnoj zaštiti od oksidacijskog stresa, upale i apoptoze. U ovom je istraživanju 
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hemin (0,5 %) primijenjen lokalno na ekscizijske rane te je procijenjen njegov terapijski učinak na cijeljenje rana u 
dijabetičnih štakora. Lokalna aplikacija hemina znakovito je povećala postotak zatvaranja rana 2. dan u dijabetičnih 
štakora, što je učinio i povidon-jod 7. dan u kontrolnoj skupini. Znakovit porast sadržaja hidroksiprolina i glukozamina 
pronađen je 14. dan u dijabetičnih štakora čije su rane tretirane heminom, za razliku od kontrolne skupine. Histologija 
je u štakora tretiranih heminom bila u skladu sa staničnom proliferacijom i sintezom kolagena u granulacijskom tkivu. 
Hemin je znakovito povisio citokin IL-10 i smanjio TNF-α u granulacijskom tkivu dijabetičnih štakora sa zacijeljenim 
ranama. Taj nalaz odgovara ljekovitom učinku hemina što je podržano inhibicijom ekspresije mRNA proupalnog 
citokina TNF-α i adhezijom molekule ICAM-1 te regulacijom protuupalnog cittokina IL-10 mRNA. Dakle, lokalna 
primjena hemina pomaže (i) u ranoj i brzoj kontrakciji rana (ii), poboljšava sadržaj hidroksiprolina i glukozamina u 
ranama i (iii) prilagođuje mRNA ekspresiju citokina u smjeru cijeljenja rane.
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